One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Pfizer has selected MacKay Jimeson and Niesha Foster as corporate affairs category leads after a reorganization of the company’s global innovative pharma business unit. The pharma giant recently ...

The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi. The Pfizer restructuring ...

This is what we cannot help but wonder about Pfizer Inc. (NYSE: PFE) after the company announced on Monday that it is restructuring ... of a corporate break-up, and that is after Pfizer has ...

Reuters Market Eye - Shares of Pfizer Ltd(NSI:PFIZER) surged as much as 18.1 percent to mark their highest intraday level since December 9, after the company said a unit of its parent Pfizer Inc ...

Pfizer sent sales and marketing executive Olivier Brandicourt to a Goldman Sachs conference Thursday to persuade investors that the drug maker is remaking itself in a hurry. Brandicourt was quite ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the development of the ...

Pfizer plans to make this new organizational structure effective at the beginning of 2019. 2. Why Pfizer is restructuring . Pfizer mentioned two reasons for reorganizing into three business segments.

Pfizer (NYSE: PFE) was in the news Wednesday for a second day in a row. On Tuesday, the company announced that it was holding off on price. 4 Things You Need to Know About Pfizer's Restructuring ...